▶ 調査レポート

感染予防および経腸アクセスの世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Infection Prevention and Enteral Access Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。感染予防および経腸アクセスの世界市場 2020年:メーカー別、地域別、種類・用途別 / Global Infection Prevention and Enteral Access Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D005-08765資料のイメージです。• レポートコード:D005-08765
• 出版社/出版日:GlobalInfoResearch / 2020年5月22日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、104ページ
• 納品方法:Eメール
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Multi User¥783,000 (USD5,220)▷ お問い合わせ
  Corporate User¥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、感染予防および経腸アクセスの世界市場を広く調査・分析し、今後の市場展望をまとめております。感染予防および経腸アクセスの種類別市場規模(経腸栄養ポンプ、経腸栄養チューブ、投与リザーバー、給水セット、経腸注射器)、用途別市場規模(腫瘍学、消化器病学、糖尿病、神経疾患、代謝亢進、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Cook Medical、Pacific Hospital Supply、CONMED Corporation、Medtronic plc、ALCOR Scientific、Boston Scientific Corporation、Vygon SA、CR Bard、CORPAK MedSystems、Teleflexorporated
・地域別グローバル市場分析 2015年-2020年
・感染予防および経腸アクセスの北米市場(アメリカ、カナダ、メキシコ)
・感染予防および経腸アクセスのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・感染予防および経腸アクセスのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・感染予防および経腸アクセスの南米市場(ブラジル、アルゼンチン)
・感染予防および経腸アクセスの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:経腸栄養ポンプ、経腸栄養チューブ、投与リザーバー、給水セット、経腸注射器
・用途別分析:腫瘍学、消化器病学、糖尿病、神経疾患、代謝亢進、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Infection Prevention and Enteral Access market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Infection Prevention and Enteral Access market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Infection Prevention and Enteral Access market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Infection Prevention and Enteral Access market has been segmented into
Enteral Feeding Pumps
Enteral Feeding Tubes
Administration Reservoirs
Giving Sets
Enteral Syringes

By Application, Infection Prevention and Enteral Access has been segmented into:
Oncology
Gastroenterology
Diabetes
Neurological Disorders
Hypermetabolism
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Infection Prevention and Enteral Access market presented in the report. This section sheds light on the sales growth of different regional and country-level Infection Prevention and Enteral Access markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Infection Prevention and Enteral Access market.

The report offers in-depth assessment of the growth and other aspects of the Infection Prevention and Enteral Access market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Infection Prevention and Enteral Access Market Share Analysis
Infection Prevention and Enteral Access competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Infection Prevention and Enteral Access sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Infection Prevention and Enteral Access sales, revenue and market share for each player covered in this report.

The major players covered in Infection Prevention and Enteral Access are:
Cook Medical
Pacific Hospital Supply
CONMED Corporation
Medtronic plc
ALCOR Scientific
Boston Scientific Corporation
Vygon SA
CR Bard
CORPAK MedSystems
Teleflexorporated

Among other players domestic and global, Infection Prevention and Enteral Access market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Infection Prevention and Enteral Access product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Infection Prevention and Enteral Access, with price, sales, revenue and global market share of Infection Prevention and Enteral Access in 2018 and 2019.
Chapter 3, the Infection Prevention and Enteral Access competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Infection Prevention and Enteral Access breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Infection Prevention and Enteral Access market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Infection Prevention and Enteral Access sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Infection Prevention and Enteral Access Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Infection Prevention and Enteral Access Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Enteral Feeding Pumps
1.2.3 Enteral Feeding Tubes
1.2.4 Administration Reservoirs
1.2.5 Giving Sets
1.2.6 Enteral Syringes
1.3 Market Analysis by Application
1.3.1 Overview: Global Infection Prevention and Enteral Access Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Gastroenterology
1.3.4 Diabetes
1.3.5 Neurological Disorders
1.3.6 Hypermetabolism
1.3.7 Others
1.4 Overview of Global Infection Prevention and Enteral Access Market
1.4.1 Global Infection Prevention and Enteral Access Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Cook Medical
2.1.1 Cook Medical Details
2.1.2 Cook Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Cook Medical SWOT Analysis
2.1.4 Cook Medical Product and Services
2.1.5 Cook Medical Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pacific Hospital Supply
2.2.1 Pacific Hospital Supply Details
2.2.2 Pacific Hospital Supply Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pacific Hospital Supply SWOT Analysis
2.2.4 Pacific Hospital Supply Product and Services
2.2.5 Pacific Hospital Supply Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 CONMED Corporation
2.3.1 CONMED Corporation Details
2.3.2 CONMED Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 CONMED Corporation SWOT Analysis
2.3.4 CONMED Corporation Product and Services
2.3.5 CONMED Corporation Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Medtronic plc
2.4.1 Medtronic plc Details
2.4.2 Medtronic plc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Medtronic plc SWOT Analysis
2.4.4 Medtronic plc Product and Services
2.4.5 Medtronic plc Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 ALCOR Scientific
2.5.1 ALCOR Scientific Details
2.5.2 ALCOR Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 ALCOR Scientific SWOT Analysis
2.5.4 ALCOR Scientific Product and Services
2.5.5 ALCOR Scientific Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boston Scientific Corporation
2.6.1 Boston Scientific Corporation Details
2.6.2 Boston Scientific Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Boston Scientific Corporation SWOT Analysis
2.6.4 Boston Scientific Corporation Product and Services
2.6.5 Boston Scientific Corporation Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Vygon SA
2.7.1 Vygon SA Details
2.7.2 Vygon SA Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Vygon SA SWOT Analysis
2.7.4 Vygon SA Product and Services
2.7.5 Vygon SA Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 CR Bard
2.8.1 CR Bard Details
2.8.2 CR Bard Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 CR Bard SWOT Analysis
2.8.4 CR Bard Product and Services
2.8.5 CR Bard Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 CORPAK MedSystems
2.9.1 CORPAK MedSystems Details
2.9.2 CORPAK MedSystems Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 CORPAK MedSystems SWOT Analysis
2.9.4 CORPAK MedSystems Product and Services
2.9.5 CORPAK MedSystems Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Teleflexorporated
2.10.1 Teleflexorporated Details
2.10.2 Teleflexorporated Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Teleflexorporated SWOT Analysis
2.10.4 Teleflexorporated Product and Services
2.10.5 Teleflexorporated Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Infection Prevention and Enteral Access Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Infection Prevention and Enteral Access Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Infection Prevention and Enteral Access Manufacturer Market Share in 2019
3.3.2 Top 6 Infection Prevention and Enteral Access Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Infection Prevention and Enteral Access Sales, Revenue and Market Share by Regions
4.1.1 Global Infection Prevention and Enteral Access Sales and Market Share by Regions (2015-2020)
4.1.2 Global Infection Prevention and Enteral Access Revenue and Market Share by Regions (2015-2020)
4.2 North America Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
4.3 Europe Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
4.5 South America Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Infection Prevention and Enteral Access Sales, Revenue and Market Share by Country
5.1.1 North America Infection Prevention and Enteral Access Sales and Market Share by Country (2015-2020)
5.1.2 North America Infection Prevention and Enteral Access Revenue and Market Share by Country (2015-2020)
5.2 United States Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
5.3 Canada Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
5.4 Mexico Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Infection Prevention and Enteral Access Sales, Revenue and Market Share by Country
6.1.1 Europe Infection Prevention and Enteral Access Sales and Market Share by Country (2015-2020)
6.1.2 Europe Infection Prevention and Enteral Access Revenue and Market Share by Country (2015-2020)
6.2 Germany Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
6.3 UK Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
6.4 France Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
6.5 Russia Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
6.6 Italy Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Infection Prevention and Enteral Access Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Infection Prevention and Enteral Access Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Infection Prevention and Enteral Access Revenue and Market Share by Regions (2015-2020)
7.2 China Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
7.3 Japan Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
7.4 Korea Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
7.5 India Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
7.7 Australia Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Infection Prevention and Enteral Access Sales, Revenue and Market Share by Country
8.1.1 South America Infection Prevention and Enteral Access Sales and Market Share by Country (2015-2020)
8.1.2 South America Infection Prevention and Enteral Access Revenue and Market Share by Country (2015-2020)
8.2 Brazil Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
8.3 Argentina Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Infection Prevention and Enteral Access Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Infection Prevention and Enteral Access Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Infection Prevention and Enteral Access Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
9.3 Turkey Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
9.4 Egypt Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
9.5 South Africa Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Infection Prevention and Enteral Access Sales and Market Share by Type (2015-2020)
10.2 Global Infection Prevention and Enteral Access Revenue and Market Share by Type (2015-2020)
10.3 Global Infection Prevention and Enteral Access Price by Type (2015-2020)
11 Global Infection Prevention and Enteral Access Market Segment by Application
11.1 Global Infection Prevention and Enteral Access Sales Market Share by Application (2015-2020)
11.2 Global Infection Prevention and Enteral Access Revenue Market Share by Application (2015-2020)
11.3 Global Infection Prevention and Enteral Access Price by Application (2015-2020)
12 Market Forecast
12.1 Global Infection Prevention and Enteral Access Sales, Revenue and Growth Rate (2021-2025)
12.2 Infection Prevention and Enteral Access Market Forecast by Regions (2021-2025)
12.2.1 North America Infection Prevention and Enteral Access Market Forecast (2021-2025)
12.2.2 Europe Infection Prevention and Enteral Access Market Forecast (2021-2025)
12.2.3 Asia-Pacific Infection Prevention and Enteral Access Market Forecast (2021-2025)
12.2.4 South America Infection Prevention and Enteral Access Market Forecast (2021-2025)
12.2.5 Middle East & Africa Infection Prevention and Enteral Access Market Forecast (2021-2025)
12.3 Infection Prevention and Enteral Access Market Forecast by Type (2021-2025)
12.3.1 Global Infection Prevention and Enteral Access Sales Forecast by Type (2021-2025)
12.3.2 Global Infection Prevention and Enteral Access Market Share Forecast by Type (2021-2025)
12.4 Infection Prevention and Enteral Access Market Forecast by Application (2021-2025)
12.4.1 Global Infection Prevention and Enteral Access Sales Forecast by Application (2021-2025)
12.4.2 Global Infection Prevention and Enteral Access Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Infection Prevention and Enteral Access Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Infection Prevention and Enteral Access by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Infection Prevention and Enteral Access Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Cook Medical Basic Information, Manufacturing Base and Competitors
Table 8. Cook Medical Infection Prevention and Enteral Access Major Business
Table 9. Cook Medical Infection Prevention and Enteral Access Total Revenue (USD Million) (2017-2018)
Table 10. Cook Medical SWOT Analysis
Table 11. Cook Medical Infection Prevention and Enteral Access Product and Services
Table 12. Cook Medical Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Pacific Hospital Supply Basic Information, Manufacturing Base and Competitors
Table 14. Pacific Hospital Supply Infection Prevention and Enteral Access Major Business
Table 15. Pacific Hospital Supply Infection Prevention and Enteral Access Total Revenue (USD Million) (2017-2018)
Table 16. Pacific Hospital Supply SWOT Analysis
Table 17. Pacific Hospital Supply Infection Prevention and Enteral Access Product and Services
Table 18. Pacific Hospital Supply Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. CONMED Corporation Basic Information, Manufacturing Base and Competitors
Table 20. CONMED Corporation Infection Prevention and Enteral Access Major Business
Table 21. CONMED Corporation Infection Prevention and Enteral Access Total Revenue (USD Million) (2017-2018)
Table 22. CONMED Corporation SWOT Analysis
Table 23. CONMED Corporation Infection Prevention and Enteral Access Product and Services
Table 24. CONMED Corporation Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Medtronic plc Basic Information, Manufacturing Base and Competitors
Table 26. Medtronic plc Infection Prevention and Enteral Access Major Business
Table 27. Medtronic plc Infection Prevention and Enteral Access Total Revenue (USD Million) (2017-2018)
Table 28. Medtronic plc SWOT Analysis
Table 29. Medtronic plc Infection Prevention and Enteral Access Product and Services
Table 30. Medtronic plc Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. ALCOR Scientific Basic Information, Manufacturing Base and Competitors
Table 32. ALCOR Scientific Infection Prevention and Enteral Access Major Business
Table 33. ALCOR Scientific Infection Prevention and Enteral Access Total Revenue (USD Million) (2017-2018)
Table 34. ALCOR Scientific SWOT Analysis
Table 35. ALCOR Scientific Infection Prevention and Enteral Access Product and Services
Table 36. ALCOR Scientific Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 38. Boston Scientific Corporation Infection Prevention and Enteral Access Major Business
Table 39. Boston Scientific Corporation Infection Prevention and Enteral Access Total Revenue (USD Million) (2017-2018)
Table 40. Boston Scientific Corporation SWOT Analysis
Table 41. Boston Scientific Corporation Infection Prevention and Enteral Access Product and Services
Table 42. Boston Scientific Corporation Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Vygon SA Basic Information, Manufacturing Base and Competitors
Table 44. Vygon SA Infection Prevention and Enteral Access Major Business
Table 45. Vygon SA Infection Prevention and Enteral Access Total Revenue (USD Million) (2017-2018)
Table 46. Vygon SA SWOT Analysis
Table 47. Vygon SA Infection Prevention and Enteral Access Product and Services
Table 48. Vygon SA Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. CR Bard Basic Information, Manufacturing Base and Competitors
Table 50. CR Bard Infection Prevention and Enteral Access Major Business
Table 51. CR Bard Infection Prevention and Enteral Access Total Revenue (USD Million) (2017-2018)
Table 52. CR Bard SWOT Analysis
Table 53. CR Bard Infection Prevention and Enteral Access Product and Services
Table 54. CR Bard Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. CORPAK MedSystems Basic Information, Manufacturing Base and Competitors
Table 56. CORPAK MedSystems Infection Prevention and Enteral Access Major Business
Table 57. CORPAK MedSystems Infection Prevention and Enteral Access Total Revenue (USD Million) (2017-2018)
Table 58. CORPAK MedSystems SWOT Analysis
Table 59. CORPAK MedSystems Infection Prevention and Enteral Access Product and Services
Table 60. CORPAK MedSystems Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Teleflexorporated Basic Information, Manufacturing Base and Competitors
Table 62. Teleflexorporated Infection Prevention and Enteral Access Major Business
Table 63. Teleflexorporated Infection Prevention and Enteral Access Total Revenue (USD Million) (2017-2018)
Table 64. Teleflexorporated SWOT Analysis
Table 65. Teleflexorporated Infection Prevention and Enteral Access Product and Services
Table 66. Teleflexorporated Infection Prevention and Enteral Access Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Infection Prevention and Enteral Access Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Infection Prevention and Enteral Access Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Infection Prevention and Enteral Access Sales by Regions (2015-2020) (K Units)
Table 70. Global Infection Prevention and Enteral Access Sales Market Share by Regions (2015-2020)
Table 71. Global Infection Prevention and Enteral Access Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Infection Prevention and Enteral Access Sales by Countries (2015-2020) (K Units)
Table 73. North America Infection Prevention and Enteral Access Sales Market Share by Countries (2015-2020)
Table 74. North America Infection Prevention and Enteral Access Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Infection Prevention and Enteral Access Revenue Market Share by Countries (2015-2020)
Table 76. Europe Infection Prevention and Enteral Access Sales by Countries (2015-2020) (K Units)
Table 77. Europe Infection Prevention and Enteral Access Sales Market Share by Countries (2015-2020)
Table 78. Europe Infection Prevention and Enteral Access Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Infection Prevention and Enteral Access Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Infection Prevention and Enteral Access Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Infection Prevention and Enteral Access Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Infection Prevention and Enteral Access Sales by Countries (2015-2020) (K Units)
Table 83. South America Infection Prevention and Enteral Access Sales Market Share by Countries (2015-2020)
Table 84. South America Infection Prevention and Enteral Access Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Infection Prevention and Enteral Access Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Infection Prevention and Enteral Access Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Infection Prevention and Enteral Access Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Infection Prevention and Enteral Access Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Infection Prevention and Enteral Access Revenue Market Share by Countries (2015-2020)
Table 90. Global Infection Prevention and Enteral Access Sales by Type (2015-2020) (K Units)
Table 91. Global Infection Prevention and Enteral Access Sales Share by Type (2015-2020)
Table 92. Global Infection Prevention and Enteral Access Revenue by Type (2015-2020) (USD Million)
Table 93. Global Infection Prevention and Enteral Access Revenue Share by Type (2015-2020)
Table 94. Global Infection Prevention and Enteral Access Sales by Application (2015-2020) (K Units)
Table 95. Global Infection Prevention and Enteral Access Sales Share by Application (2015-2020)
Table 96. Global Infection Prevention and Enteral Access Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Infection Prevention and Enteral Access Market Share Forecast by Regions (2021-2025)
Table 98. Global Infection Prevention and Enteral Access Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Infection Prevention and Enteral Access Market Share Forecast by Type (2021-2025)
Table 100. Global Infection Prevention and Enteral Access Sales Forecast by Application (2021-2025)
Table 101. Global Infection Prevention and Enteral Access Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Infection Prevention and Enteral Access Picture
Figure 2. Global Sales Market Share of Infection Prevention and Enteral Access by Type in 2019
Figure 3. Enteral Feeding Pumps Picture
Figure 4. Enteral Feeding Tubes Picture
Figure 5. Administration Reservoirs Picture
Figure 6. Giving Sets Picture
Figure 7. Enteral Syringes Picture
Figure 8. Infection Prevention and Enteral Access Sales Market Share by Application in 2018
Figure 9. Oncology Picture
Figure 10. Gastroenterology Picture
Figure 11. Diabetes Picture
Figure 12. Neurological Disorders Picture
Figure 13. Hypermetabolism Picture
Figure 14. Others Picture
Figure 15. Global Infection Prevention and Enteral Access Market Status and Outlook (2015-2025) (USD Million)
Figure 16. United States Infection Prevention and Enteral Access Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Canada Infection Prevention and Enteral Access Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Mexico Infection Prevention and Enteral Access Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Germany Infection Prevention and Enteral Access Revenue (Value) and Growth Rate (2015-2025)
Figure 20. France Infection Prevention and Enteral Access Revenue (Value) and Growth Rate (2015-2025)
Figure 21. UK Infection Prevention and Enteral Access Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Russia Infection Prevention and Enteral Access Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Italy Infection Prevention and Enteral Access Revenue (Value) and Growth Rate (2015-2025)
Figure 24. China Infection Prevention and Enteral Access Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Japan Infection Prevention and Enteral Access Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Korea Infection Prevention and Enteral Access Revenue (Value) and Growth Rate (2015-2025)
Figure 27. India Infection Prevention and Enteral Access Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Southeast Asia Infection Prevention and Enteral Access Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Australia Infection Prevention and Enteral Access Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 30. Brazil Infection Prevention and Enteral Access Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Egypt Infection Prevention and Enteral Access Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Saudi Arabia Infection Prevention and Enteral Access Revenue (Value) and Growth Rate (2015-2025)
Figure 33. South Africa Infection Prevention and Enteral Access Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Turkey Infection Prevention and Enteral Access Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Global Infection Prevention and Enteral Access Sales Market Share by Manufacturer in 2019
Figure 36. Global Infection Prevention and Enteral Access Revenue Market Share by Manufacturer in 2019
Figure 37. Top 3 Infection Prevention and Enteral Access Manufacturer (Revenue) Market Share in 2019
Figure 38. Top 6 Infection Prevention and Enteral Access Manufacturer (Revenue) Market Share in 2019
Figure 39. Key Manufacturer Market Share Trend
Figure 40. Global Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020) (K Units)
Figure 41. Global Infection Prevention and Enteral Access Revenue and Growth Rate (2015-2020) (USD Million)
Figure 42. Global Infection Prevention and Enteral Access Revenue Market Share by Regions (2015-2020)
Figure 43. Global Infection Prevention and Enteral Access Revenue Market Share by Regions in 2018
Figure 44. North America Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
Figure 45. Europe Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
Figure 47. South America Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
Figure 48. Middle East & Africa Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020)
Figure 49. North America Infection Prevention and Enteral Access Revenue and Growth Rate (2015-2020) (USD Million)
Figure 50. North America Infection Prevention and Enteral Access Sales Market Share by Countries (2015-2020)
Figure 51. North America Infection Prevention and Enteral Access Sales Market Share by Countries in 2018
Figure 52. North America Infection Prevention and Enteral Access Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 53. North America Infection Prevention and Enteral Access Revenue Market Share by Countries in 2018
Figure 54. United States Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Canada Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Mexico Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Europe Infection Prevention and Enteral Access Revenue and Growth Rate (2015-2020) (USD Million)
Figure 58. Europe Infection Prevention and Enteral Access Revenue Market Share by Countries (2015-2020)
Figure 59. Europe Infection Prevention and Enteral Access Revenue Market Share by Countries in 2019
Figure 60. Germany Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020) (K Units)
Figure 61. UK Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020) (K Units)
Figure 62. France Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Russia Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Italy Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Asia-Pacific Infection Prevention and Enteral Access Revenue and Growth Rate (2015-2020) (USD Million)
Figure 66. Asia-Pacific Infection Prevention and Enteral Access Sales Market Share by Regions 2019
Figure 67. Asia-Pacific Infection Prevention and Enteral Access Revenue Market Share by Regions 2019
Figure 68. China Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Japan Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Korea Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020) (K Units)
Figure 71. India Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Southeast Asia Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020) (K Units)
Figure 73. South America Infection Prevention and Enteral Access Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. South America Infection Prevention and Enteral Access Sales Market Share by Countries in 2019
Figure 75. South America Infection Prevention and Enteral Access Revenue Market Share by Countries in 2019
Figure 76. Brazil Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Argentina Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Middle East and Africa Infection Prevention and Enteral Access Revenue and Growth Rate (2015-2020) (USD Million)
Figure 79. Middle East and Africa Infection Prevention and Enteral Access Sales Market Share by Countries in 2019
Figure 80. Middle East and Africa Infection Prevention and Enteral Access Revenue Market Share by Countries (2015-2020)
Figure 81. Middle East and Africa Infection Prevention and Enteral Access Revenue Market Share by Countries in 2019
Figure 82. Saudi Arabia Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Egypt Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Turkey Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020) (K Units)
Figure 85. South Africa Infection Prevention and Enteral Access Sales and Growth Rate (2015-2020) (K Units)
Figure 86. Global Infection Prevention and Enteral Access Sales and Growth Rate (2021-2025) (K Units)
Figure 87. Global Infection Prevention and Enteral Access Revenue and Growth Rate (2021-2025) (USD Million)
Figure 88. North America Sales Infection Prevention and Enteral Access Market Forecast (2021-2025) (K Units)
Figure 89. Europe Sales Infection Prevention and Enteral Access Market Forecast (2021-2025) (K Units)
Figure 90. Asia-Pacific Sales Infection Prevention and Enteral Access Market Forecast (2021-2025) (K Units)
Figure 91. South America Sales Infection Prevention and Enteral Access Market Forecast (2021-2025) (K Units)
Figure 92. Middle East & Africa Sales Infection Prevention and Enteral Access Market Forecast (2021-2025) (K Units)
Figure 93. Sales Channel: Direct Channel vs Indirect Channel